We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
- Authors
Cox, Maria Christina; Musuraca, Gerardo; Battistini, Roberta; Casaroli, Ivana; Zoli, Valerio; Anticoli‐Borza, Paola; Arcari, Annalisa; Naso, Virginia; di Landro, Francesca; Fabbri, Francesca; Tafuri, Agostino; Bocci, Guido; Merli, Francesco
- Abstract
The article discusses the effectiveness of the oral metronomic chemotherapy (MC), DEVEC (Deltacortene, etoposide, vinorelbine, cyclophosphamide), as treatment for aggressive lymphomas in elderly patients. Also cited are the study conducted on patients with aggressive B- and T-cell lymphomas, as well as the results like estimated median overall survival (OS), progression-free survival (PFS), and the estimated direct cost of drugs.
- Subjects
LYMPHOMA treatment; OLDER patients; CANCER chemotherapy; B cell lymphoma; T-cell lymphoma; PROGRESSION-free survival; VINORELBINE
- Publication
British Journal of Haematology, 2018, Vol 183, Issue 5, p819
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.15039